Business Trends– category –
-
U.S. Department of Energy Commits $29 Million in R&D Funding to Advance Solar Manufacturing, PV Recycling, and Perovskite Development
U.S. Department of Energy (DOE) Solar Energy Technologies Office (SETO) USA Overview The U.S. Department of Energy (DOE) has announced a $29 million R&D funding initiative to promote enhanced PV recyclability, reduced manufacturing c... -
Oxford PV Initiates Commercial Production and Shipment of Perovskite-Silicon Tandem Solar Cells in 2026, Achieving 24-27% Module Efficiency
EIN Presswire UK Overview Oxford PV, a UK pioneer, officially commenced commercial production and shipment of perovskite-silicon tandem solar cells in 2026, achieving module efficiencies of 24% to 27%. This marks a critical milestone in ... -
Lumos Diagnostics Partners with Alpha Medical for Exclusive Romanian Distribution of FebriDx Rapid Respiratory Infection Test, Boosting European Expansion
MarketScreener Australia Overview Lumos Diagnostics Holdings has announced an exclusive distribution agreement with Romania's Alpha Medical for the commercialization of its FebriDx rapid respiratory infection POCT diagnostic test across ... -
Cizzle Biotechnology Launches CIZ1B Blood Test for Early Lung Cancer Detection in US Market
The York Press UK Overview UK-based Cizzle Biotechnology Holdings has commenced the commercial rollout of its CIZ1B biomarker blood test for early lung cancer detection in the United States. The initial launch in Dallas-Fort Worth and Sa... -
Trinity Biotech and Latch Medical Partner to Develop Precision Therapies for Metabolic Conditions Using Real-Time Biosensor Data
BioWorld International Overview Trinity Biotech plc has partnered with Latch Medical Ltd. to integrate data from Trinity's CGM+ wearable biosensor platform with Latch Medical's drug delivery technologies. The collaboration aims to develo... -
3D Bioprinting Innovator Partners with MedTech Giant to Commercialize Regenerative Therapies
Specialized Media / Company Announcement USA Overview A pioneering 3D bioprinting company has announced a strategic licensing agreement with a leading medical device manufacturer, targeting the regenerative medicine sector. This partners... -
ClinicalTrials.gov Updates Phase 2 Trial Registration for iPSC-Derived Retinal Pigment Epithelium Cell Transplantation for Age-Related Macular Degeneration
ClinicalTrials.gov USA Overview Information regarding a Phase 2 clinical trial for iPSC-derived Retinal Pigment Epithelium (RPE) cell transplantation targeting Age-related Macular Degeneration (AMD) has been updated or newly registered o... -
Exosome Therapeutics Firm Unveils Advanced Platform, Pipeline Progress Targeting Regenerative Medicine and Enhanced Drug Delivery
Company Disclosures USA Overview An exosome-based therapeutics company has detailed significant pipeline advancements and its cutting-edge technology platform at a recent investor briefing. The presentation particularly emphasized exosom... -
Pharma Giant Acquires Gene-Editing Pioneer, Bolstering Pipeline and Redefining R&D
Specialized Media USA Overview A leading pharmaceutical company has acquired a smaller biotechnology firm specializing in innovative gene-editing platforms. This strategic move aims to integrate cutting-edge gene therapy modalities into ... -
FDA Bestows RMAT Status on iPSC-Derived Cell Therapy for Intractable Disease, Poised to Accelerate Clinical Development
Company Announcement / Specialized Media USA Overview A regenerative medicine firm has announced its iPSC-derived cell therapy program for an intractable disease has received Regenerative Medicine Advanced Therapy (RMAT) designation from...
